Is "TTM" safe to use?

"TTM" (Targeted Temperature Management) is a complex medical procedure, not inherently "safe" but generally beneficial and recommended for certain patients (like after cardiac arrest) when risks are managed, though it carries significant potential complications like electrolyte issues, infections, and cardiovascular problems, requiring careful monitoring. Its safety depends heavily on the specific patient, clinical condition, and precise management, with newer research questioning its benefit over normothermia (normal temperature) in some cases.

What are the risks of TTM?

Risk and complications

TTM may lead to fluid and electrolyte imbalances, arrhythmias, insulin resistance, shivering, coagulation problems, pancreatitis, infection, skin breakdown and other adverse effects.

What should be avoided in TTM?

Avoid fever following targeted temperature management (TTM), as any elevated temperature is associated with worse neurologic outcome. Avoid hypoxia, with administration of oxygen saturation above 94%. However, hyperoxia is also harmful.

Does TTM actually work?

Although laboratory science has repeatedly shown a clear survival benefit following cardiac arrest when TTM is used (and indeed, with a strong dose–effect relationship), similar results have been elusive in clinical trials, with some trials showing benefit and others showing no clinical effect when TTM is employed (Fig ...

How long does TTM treatment last?

Targeted Temperature Management means "manipulating body temperature for a given therapeutic goal." TTM therapy intentionally lower's a patient's body temperature for 24 hours to around 91°F, or in other cases 97°F (normal body temperature is about 98.6°F).

Hypothermia , UPDATE - Everything You Need To Know - Dr. Nabil Ebraheim

What is the best medication for trichotillomania?

Results. SSRIs and clomipramine are considered first-line in TTM. In addition, family members of TTM patients are often affected by obsessive-compulsive spectrum disorders. Other drugs used in the treatment of TTM are lamotrigine, olanzapine, N-Acetylcysteine, inositol, and naltrexone.

Why do we use TTM?

TTM is used to evaluate commercial real estate investments by providing a snapshot of the last 12 months of financial activity. Investors, lenders, and others can use TTM to calculate documents such as income statements, balance sheets, and cash flow statements.

How long should you do TTM?

TTM should be induced and maintained at the selected target temperature for 24 hours, and rewarmed gradually at a rate not faster than 0.5°C per hour. Every hour of delay in TTM after ROSC increases mortality by 20%. Thus, TTM should be initiated as soon as possible after ROSC.

What are the benefits of TTM?

Temperature management is believed to decrease swelling and pressure in the brain which can cause further complications after a cardiac arrest. This can also decrease the frequency of seizures.

What is the success rate of therapeutic hypothermia?

Therapeutic hypothermia group. There were 128 patients treated with hypothermia. Eighty-two (64%) survived and 88% of survivors achieved a favorable functional outcome (CPC score ≤2) at hospital discharge.

What are the risks of therapeutic hypothermia?

Some of these risks include:

• Another abnormal heart rhythm, especially slow heart rates.
• Severe blood infection (sepsis)
• Blood is less able to clot. This can cause bleeding.
• Electrolyte and metabolic problems.
• Raised blood sugar levels.
• Imbalance of the pH (acid-base) levels in the body.

What medical conditions use TTM?

TTM is effective in five primary categories of medical events:

• Neonatal encephalopathy.
• Cardiac arrest.
• Ischemic stroke.
• Traumatic brain or spinal cord injury without a fever.
• Neurogenic fever following brain trauma.

How long should you wait to determine the neurologic prognosis of a patient treated with targeted temperature management after the patient returns to normothermia?

➢ Patients should continue to receive aggressive post-cardiac arrest care, including 48 hours of post- rewarming normothermia and avoidance of neuro-prognostication for at least 72 hours after rewarming to 37 C.

What are the risks of targeted therapy?

What are common side effects of targeted therapy?

• Skin, hair, and nail changes. Many targeted therapies cause skin, hair, and nail changes (including hair loss). ...
• Allergic or infusion reactions. ...
• High blood pressure. ...
• Bleeding or blood clotting problems. ...
• Slow wound healing. ...
• Heart damage. ...
• Autoimmune reactions. ...
• Swelling.

When to use TTM?

Indications

1. TTM to treat patients who are comatose after out of hospital cardiac arrest with initial rhythms of pulseless ventricular tachycardia or ventricular fibrillation (Class 1, strong)
2. TTM to treat patients who are comatose after in-hospital cardiac arrest and patients with non-shockable rhythms (Class 1, strong)

Who is a candidate for TTM?

Any survivor of cardiac arrest who is comatose (defined as unarousable unresponsiveness to external stimuli) should be considered as a candidate for TTM regardless of the initial presenting rhythm, and the decision to opt for targeted hypothermia versus targeted normothermia should be made on a case-by-case basis.

What are the cons of the TTM?

The model also assumes that people logically plan out their behavior changes, but decision-making is often skewed away from rationality by emotions, cognitive biases, and external pressures. These drawbacks may explain why research on the TTM yields inconsistent results.

Does TTM work?

Although laboratory science has repeatedly shown a clear survival benefit following cardiac arrest when TTM is used (and indeed, with a strong dose–effect relationship), similar results have been elusive in clinical trials, with some trials showing benefit and others showing no clinical effect when TTM is employed (Fig ...

What are the alternatives to TTM?

TTM's top competitors include Nucleon Security, Crossword Cybersecurity, and BroadBand Security. Nucleon Security is a cybersecurity company that focuses on endpoint protection and vulnerability management. The company's main offering is the Nucleon Smart Endpoint …

When to stop cooling therapy?

Therapeutic hypothermia should be continued for 72 hours, with a target rectal (or esophageal) temperature of 33°C to 34°C for whole body cooling, or 34°C to 35°C for selective head cooling. Rewarming should occur over 6 to 12 hours (0.5°C every 1 to 2 hours).

How long should you do physical therapy a day?

A General Rule of Thumb

For most people, physical therapy at home should be performed 5–7 days a week, with sessions ranging from 20 to 45 minutes, depending on the goals. In some cases, shorter, more frequent sessions (such as 2 or 3 mini-sessions daily) are better for promoting healing, especially early in recovery.

What are the contraindications for therapeutic hypothermia?

Contraindications. There are few true contraindications for TH. Medical conditions in which the risk may be excessive include documented intracranial hemorrhage, severe hemorrhage leading to exsanguination, hypotension refractory to multiple vasopressors, severe sepsis, and pregnancy.

When do you use TTM?

TTM means Trailing Twelve Months. It's a term used to describe the past 12 months of consecutive financial or performance data for a business. Another name for TTM is Last Twelve Months (LTM). TTM is used to analyze the most recent data rather than relying on the last fiscal year's numbers.

Is TTM accurate?

TTM offers a more accurate and thorough picture of a company's financial performance while TSM may be valuable for examining short-term trends or addressing urgent difficulties. Another financial metric that resembles TTM is the current year-to-date (YTD).

What is good TTM?

For investors, TTM revenue is a good indicator of how your business is trending. If your revenue has been on an incline over the past 12 months, it's a sign of growth. On the other hand, if your revenue is up and down or declining, it can signal a red flag for investors.